The world's most-watched equity benchmark is once again knocking on the door of record territory, yet the path forward is ...

There is a peculiar tension at the heart of SK Hynix's current market narrative. The stock has nearly tripled since January, ...

The software maker's blowout fiscal fourth-quarter results have triggered one of the most aggressive waves of Wall Street ...

Switzerland’s military has terminated its contract with Palantir Technologies Inc. following a security audit. The review concluded that U.S. intelligence agencies could potentially access sensitive ...

Roughly 1,500 demonstrators took to the streets in Kiel on June 18 to protest against proposed cuts to social benefits and potential loosening of working-time regulations. The rally, organized by ...

The Swedish fintech giant Klarna is presenting a complex picture to the market. While its core operational metrics continue to show robust expansion, a recent wave of executive departures and a ...

A dramatic collapse in share price and serious allegations of financial control failures have placed Kyndryl Holdings Incorporation in a precarious position. The company’s admission of significant ...

For investors tracking the pioneering single-cell biology firm Berkeley Lights, the search now leads to a different corporate entity. The company’s journey as an independent public stock has concluded ...

Germany’s largest premium carmaker is freezing a special contractual payment worth nearly a fifth of monthly base pay for almost its entire domestic workforce, the latest sign of mounting cost ...

BayWa’s restructuring effort is now squeezed from two sides at once. The agribusiness group has seen a key subsidiary, BayWa Bau- & Gartenmärkte GmbH & Co. KG, file for insolvency in ...

Luka Mucic faced his first annual general meeting as Vonovia’s chief executive with a bold promise to slash debt and a bitter controversy over the exit package for his predecessor. The gathering in ...

Hensoldt is navigating a paradox. The German defence sensor specialist has never had more work on its books, yet its share price is languishing near 52-week lows, caught between a Chinese export ban ...